Mefenamic acid compared with indomethacin and placebo in osteoarthritis.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003967:Diarrhea / Q000139:chemically induced; D004063:Digestion / Q000187:drug effects; D004381:Duodenal Ulcer / Q000139:chemically induced; D005260:Female; D005500:Follow-Up Studies; D006029:Glycosuria / Q000139:chemically induced; D006261:Headache / Q000139:chemically induced; D006621:Hip Joint; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects / Q000627:therapeutic use*; D007719:Knee Joint; D008297:Male; D008528:Mefenamic Acid / Q000009:adverse effects / Q000627:therapeutic use; D008551:Melena / Q000139:chemically induced; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010003:Osteoarthritis / Q000188:drug therapy*; D010146:Pain / Q000188:drug therapy; D010919:Placebos; D013997:Time Factors; D014717:Vertigo / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced; D062367:ortho-Aminobenzoates / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D010919:Placebos; D062367:ortho-Aminobenzoates; D008528:Mefenamic Acid; D007213:Indomethacin